April 6, 2022
UC San Diego has joined a Phase II clinical trial to evaluate various additional COVID-19 booster shots. The trial seeks to understand if different vaccine regimens can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot.
April 4, 2022
Charitable giving increased in counties that experienced COVID-19-related deaths, reveals a new study from the University of California San Diego’s Rady School of Management published in Nature’s Scientific Reports.
March 21, 2022
UC San Diego Health is now administering Evusheld to eligible, immunocompromised patients to protect against the COVID-19 virus.
March 17, 2022
UC San Diego study shows neuroendocrine cells in the lungs drive a developmental lung disease, and a similar brain-lung interaction may contribute to COVID-19 symptoms. The findings suggest neuropeptides may be a promising therapeutic target for conditions with excess lung fluid.
March 14, 2022
Financial incentives and other nudges have been used to help increase vaccination rates across the nation, but new research from the University of California San Diego’s Rady School of Management reveals that compensations need to be large—at least $100—to reduce vaccine hesitancy.
March 2, 2022
A recent pilot program measuring the results of online tutoring for K-12 students has shown positive, promising results, according to a new study from the University of California San Diego’s Rady School of Management.
February 15, 2022
UC San Diego Health researchers surveyed and compared early- and late-stage breast and colorectal cancer diagnoses in patients in pre-pandemic 2019 and in 2020, the first full year of the COVID-19 pandemic, discovering fewer of the former and more of the latter as patients delayed care.
January 13, 2022
Researchers studying how small worms defend themselves against pathogens have discovered a gene that acts as a first-line response against infection. They identified “ZIP-1” as a centralized hub for immune response, a finding could have implications for understanding human immunity against viruses.
December 10, 2021
Few places in the country are better equipped to detect new virus variants than San Diego, where researchers at UC San Diego School of Medicine and Scripps Research, working with county public health officials, health systems and others, collaborate to create a sort of viral early warning system.
November 22, 2021
In May 2021, the Centers for Disease Control officially recognized that SARS-CoV-2—the virus that causes COVID-19—is airborne. Now UC San Diego Professor and Endowed Chair of Chemistry and Biochemistry Rommie Amaro has modeled the delta virus inside an aerosol for the first time.